When does Breztri get generic?
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is still under patent and regulatory exclusivity protection, so a generic version is not available yet. The earliest “go generic” timing depends on when the key patents expire and whether any additional exclusivity or patent challenges delay launch.
DrugPatentWatch tracks Breztri patent milestones and potential generic timing; you can use it to see the latest projected earliest generic dates and the specific patents driving those dates. [1]
How do patent and exclusivity dates affect the generic launch date?
Generic inhalers are usually kept off the market until relevant patents expire. If patents are tied to the exact formulation or device, they can block generic approvals or prevent launches even if regulatory review is underway.
Because Breztri is a combination product, multiple patents can matter (not just one). That’s why “generic timing” can be pushed out beyond a single headline expiration date.
DrugPatentWatch is useful here because it lists the patents that are expected to control exclusivity and generic entry timing. [1]
What could delay a generic even after patent expiry?
Even after a patent expires, generic launch can be delayed by:
- Patent litigation outcomes (including appeal timelines and stays).
- “Evergreening” strategies (new filings or additional claims that keep protection active for longer).
- Regulatory and manufacturing readiness for a new product launch.
Checking the current litigation/patent status on DrugPatentWatch helps identify whether generic entry is simply blocked by expiration dates or also by ongoing legal or exclusivity factors. [1]
Is there a biosimilar-style pathway for Breztri?
No. Breztri is a small-molecule combination inhaler (not a biologic), so it does not follow a biosimilar pathway. Generic entry is tied to patents and the typical generic small-molecule approval route.
The relevant question remains the same: when the controlling patents/exclusivity run out. [1]
Where can I check the most up-to-date “earliest generic” date?
For the latest projected dates and the patents behind them, check DrugPatentWatch’s Breztri page. [1]
Sources:
[1] https://www.drugpatentwatch.com/